Xihui Wang1, Rui Yang2, Chunyan Yuan3, Yanli An3, Qiusha Tang4, Daozhen Chen5. 1. School of Medicine, Southeast University, Nanjing, 210009, People's Republic of China. 2. Wuxi Maternity and Child Health Care Hospital Affiliated to Nanjing Medical University, Wuxi, 214002, People's Republic of China. 3. Affiliated Zhong-Da Hospital of Southeast University, Nanjing, 210009, People's Republic of China. 4. School of Medicine, Southeast University, Nanjing, 210009, People's Republic of China. panyixi-tqs@163.com. 5. Wuxi Maternity and Child Health Care Hospital Affiliated to Nanjing Medical University, Wuxi, 214002, People's Republic of China. chendaozhen@163.com.
Abstract
BACKGROUND: Ovarian cancer is a common gynecologic malignancy with poor prognosis, requiring innovative new therapeutic strategies. Temperature-controlled drug delivery to cancer cells represents a novel, promising, targeted treatment approach. OBJECTIVE: We prepared folate receptor-targeted thermosensitive liposomes wrapped with the HSP90 inhibitor 17-AAG and superparamagnetic material (17-AAG/MTSLs-FA), and tested the efficacy of these targeted magnetoliposomes in vitro and in vivo. METHODS: Magnetic thermosensitive liposomes wrapped with 17-AAG were coprecipitated with Fe3O4 magnetic nanoparticles and prepared by a rotary evaporation method. Experiments were conducted with SKOV3 human ovarian cancer cells and MCF7 human breast carcinoma cells to evaluate the anti-tumor effects. RESULTS: 17-AAG/MTSLs-FA prepared in this study met the basic requirements for therapeutic application. The preparation method is relatively simple and the raw materials are readily available. The product exhibited strong magnetism, high encapsulation efficiencies, and satisfactory performance. The liposomes combined with hyperthermia significantly inhibited the proliferation of SKOV3 cells and induced apoptosis. Experiments using a mouse subcutaneous model as well as an ascites tumor xenograft model indicated that 17-AAG/MTSLs-FA was stable in vivo and effectively targeted tumor tissues expressing the folate receptor. CONCLUSIONS: Folic acid-conjugated 17-AAG magnetic thermosensitive liposomes in combination with an alternating magnetic field for heating can achieve a synergistic anti-tumor effect of chemotherapy and heat treatment, potentially offering a new method for ovarian cancer treatment.
BACKGROUND:Ovarian cancer is a common gynecologic malignancy with poor prognosis, requiring innovative new therapeutic strategies. Temperature-controlled drug delivery to cancer cells represents a novel, promising, targeted treatment approach. OBJECTIVE: We prepared folate receptor-targeted thermosensitive liposomes wrapped with the HSP90 inhibitor 17-AAG and superparamagnetic material (17-AAG/MTSLs-FA), and tested the efficacy of these targeted magnetoliposomes in vitro and in vivo. METHODS: Magnetic thermosensitive liposomes wrapped with 17-AAG were coprecipitated with Fe3O4 magnetic nanoparticles and prepared by a rotary evaporation method. Experiments were conducted with SKOV3 humanovarian cancer cells and MCF7 humanbreast carcinoma cells to evaluate the anti-tumor effects. RESULTS: 17-AAG/MTSLs-FA prepared in this study met the basic requirements for therapeutic application. The preparation method is relatively simple and the raw materials are readily available. The product exhibited strong magnetism, high encapsulation efficiencies, and satisfactory performance. The liposomes combined with hyperthermia significantly inhibited the proliferation of SKOV3 cells and induced apoptosis. Experiments using a mouse subcutaneous model as well as an ascites tumor xenograft model indicated that 17-AAG/MTSLs-FA was stable in vivo and effectively targeted tumor tissues expressing the folate receptor. CONCLUSIONS:Folic acid-conjugated 17-AAG magnetic thermosensitive liposomes in combination with an alternating magnetic field for heating can achieve a synergistic anti-tumor effect of chemotherapy and heat treatment, potentially offering a new method for ovarian cancer treatment.
Authors: Laurie Elit; Thomas K Oliver; Allan Covens; Janice Kwon; Michael Fung-Kee Fung; Holger W Hirte; Amit M Oza Journal: Cancer Date: 2007-02-15 Impact factor: 6.860
Authors: Bilyana M Dicheva; Timo L M ten Hagen; Debby Schipper; Ann L B Seynhaeve; Gerard C van Rhoon; Alexander M M Eggermont; Gerben A Koning Journal: J Control Release Date: 2014-08-29 Impact factor: 9.776
Authors: Inês Santos; Cristiano Ramos; Cindy Mendes; Catarina O Sequeira; Catarina S Tomé; Dalila G H Fernandes; Pedro Mota; Rita F Pires; Donato Urso; Ana Hipólito; Alexandra M M Antunes; João B Vicente; Sofia A Pereira; Vasco D B Bonifácio; Sofia C Nunes; Jacinta Serpa Journal: Nutrients Date: 2019-10-19 Impact factor: 5.717
Authors: Adriana Cruz; Pedro Mota; Cristiano Ramos; Rita F Pires; Cindy Mendes; José P Silva; Sofia C Nunes; Vasco D B Bonifácio; Jacinta Serpa Journal: Antioxidants (Basel) Date: 2020-02-03